Our Pricing

Buy Mounjaro Online UK - No GP Visit Required

Published on: June 03, 2026

You can buy Mounjaro online UK with no GP visit required through Cured Pharmacy's regulated clinical service. Our UK-registered prescribers assess your suitability through a secure online consultation, typically completed in under three minutes. Genuine Mounjaro (tirzepatide) KwikPens are available from £124.99, dispensed by our GPhC-registered pharmacy with discreet next-day delivery across the UK.

How to Buy Mounjaro Online UK Without Seeing Your GP

UK pharmacy regulations permit registered online prescribers to assess patients remotely for prescription-only medicines, including Mounjaro, without requiring a traditional GP appointment [1]. At Cured Pharmacy, our clinical team — led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073) — conducts thorough online assessments that meet MHRA and GPhC standards for remote prescribing.

The process involves completing a medical questionnaire covering your weight history, current medications, cardiovascular health, and any contraindications to tirzepatide therapy. A UK-registered prescriber reviews your responses, typically within hours, and approves suitable candidates for treatment [1]. This pathway is particularly valuable for patients who face long NHS waiting times or prefer the convenience of digital healthcare services.

Once approved, your prescription is dispensed from our UK-licensed pharmacy and dispatched in 100% discreet packaging. You'll receive the same genuine Mounjaro KwikPens available through traditional channels, complete with patient information leaflets and dosing guidance.

Mounjaro Clinical Evidence and Efficacy

Mounjaro contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist — the first of its class licensed by the MHRA for weight management [2]. This dual mechanism distinguishes tirzepatide from single-pathway GLP-1 treatments like semaglutide, producing enhanced metabolic effects.

The pivotal SURMOUNT-1 trial demonstrated that adults with obesity achieved average body weight reductions of 15.0%, 19.5%, and 20.9% with the 5mg, 10mg, and 15mg maintenance doses respectively over 72 weeks [2]. These results exceeded those observed in comparable semaglutide trials, positioning tirzepatide as the most effective pharmaceutical weight loss intervention currently available in the UK.

In the SURMOUNT-3 trial, participants who continued tirzepatide after an initial weight loss period maintained significantly greater weight reduction compared to those switched to placebo, with an additional 5.5% body weight loss observed [3]. This evidence supports tirzepatide's role in long-term weight management rather than short-term intervention alone.

How Tirzepatide Works in Your Body

Tirzepatide activates both GIP and GLP-1 receptors in the pancreas, gut, and brain. GLP-1 activation slows gastric emptying and reduces appetite through hypothalamic pathways, while GIP activation enhances insulin secretion and may improve fat metabolism [2]. Together, these mechanisms create a synergistic effect that addresses multiple pathways involved in weight regulation.

Most patients notice reduced hunger within the first week of treatment, with progressive weight loss becoming evident from week 4 onwards. The medication is administered as a once-weekly subcutaneous injection, typically in the abdomen, thigh, or upper arm.

Mounjaro Dosing Schedule and Treatment Protocol

UK prescribers follow a standardised dose escalation protocol to minimise gastrointestinal side effects whilst optimising efficacy. Treatment begins with 2.5mg once weekly for four weeks, serving as an initial tolerability dose rather than a therapeutic dose [1]. After this period, the dose increases to 5mg weekly — the minimum maintenance dose for weight management.

Depending on individual response and tolerability, your prescriber may recommend further increases to 7.5mg, 10mg, 12.5mg, or the maximum 15mg dose at four-week intervals. Clinical trials show that higher doses generally produce greater weight loss, but individual factors such as side effect tolerance and cardiovascular considerations influence the optimal maintenance dose for each patient [2].

At Cured Pharmacy, your UK prescriber determines your appropriate dose based on your online assessment. Pricing reflects the prescribed strength, with transparent costs displayed before you complete your consultation.

What to Expect During Dose Escalation

Gradual dose increases allow your body to adapt to tirzepatide's effects on gastric emptying and appetite regulation. Most patients tolerate escalation well, though mild nausea may occur transiently after each increase. These symptoms typically resolve within 3-5 days as your system adjusts.

Your prescriber may recommend maintaining your current dose for an additional four weeks if you experience significant side effects, rather than progressing immediately to the next strength. This flexible approach balances efficacy with tolerability.

Mounjaro vs Wegovy: Comparing UK Weight Loss Injections

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are once-weekly injectable medications licensed by the MHRA for weight management in adults with a BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities [1][4]. However, their mechanisms and clinical outcomes differ meaningfully.

Head-to-head trials have not been published comparing the two medications directly, but cross-trial comparisons suggest tirzepatide produces greater average weight loss. SURMOUNT-1 participants on the 15mg tirzepatide dose lost an average 20.9% body weight over 72 weeks [2], whilst STEP 1 participants on the 2.4mg semaglutide dose lost an average 14.9% over 68 weeks [4]. Both figures represent substantial, clinically meaningful reductions.

Pricing also differs: Mounjaro starts from £124.99 at Cured Pharmacy, whilst Wegovy begins at a lower entry price point. Your choice between the two depends on clinical factors (medical history, previous treatment response, side effect profile) and personal preferences regarding cost versus potential efficacy. Both require the same online consultation process and are dispensed with equivalent regulatory oversight.

Common Side Effects and Safety Considerations

The most frequently reported side effects of Mounjaro are gastrointestinal: nausea (reported by up to 30% of participants in clinical trials), diarrhoea, vomiting, constipation, and abdominal discomfort [2]. These effects are typically mild to moderate, occur most commonly during dose escalation, and diminish over time as your body adapts to the medication.

Rare but serious risks include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking concurrent diabetes medications). Mounjaro carries a boxed warning in the United States regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [1]. UK prescribers screen for personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 before prescribing.

Patients with a history of severe gastrointestinal disease, pancreatitis, or diabetic retinopathy require careful assessment before starting tirzepatide. Your online consultation at Cured Pharmacy includes detailed questions about these conditions to ensure safe prescribing. Our clinical team may request additional information or decline to prescribe if your medical history suggests tirzepatide is unsuitable.

Managing Side Effects Effectively

Most gastrointestinal symptoms can be minimised through dietary adjustments: eating smaller, more frequent meals; avoiding high-fat foods; staying well-hydrated; and not lying down immediately after eating. If nausea persists, over-the-counter antiemetics may provide relief, though you should consult your prescriber before adding any new medications.

Severe or persistent side effects warrant clinical review. Contact our pharmacy team on (+44) 116 4646009 if you experience sustained vomiting, signs of pancreatitis (severe abdominal pain radiating to the back), or symptoms of gallbladder inflammation.

Pricing, Delivery, and Ongoing Support at Cured Pharmacy

Transparent pricing is central to our service model. Mounjaro costs from £124.99 at Cured Pharmacy, with the exact price determined by your prescribed dose and supply duration. Unlike some online providers, we display costs before you complete your consultation, ensuring no unexpected charges at checkout.

Once your prescription is approved, we dispatch your medication via tracked courier with next-day delivery available across mainland UK. All orders arrive in plain, unmarked packaging with no external indication of contents — maintaining complete discretion. Your Mounjaro KwikPens are supplied in their original manufacturer packaging with full patient information leaflets and UK regulatory labelling.

Ongoing clinical support is included with your treatment. Our pharmacy team can answer questions about injection technique, storage requirements, missed doses, and side effect management. If you need to adjust your dose or discuss treatment response, our prescribers are available for follow-up consultations. We also offer automatic refill reminders to ensure continuity of treatment without interruption.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. GOV.UK. https://products.mhra.gov.uk/ [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Aronne, L. J., Sattar, N., Horn, D. B., et al. (2024). Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical Trial. JAMA, 331(1), 38–48. https://doi.org/10.1001/jama.2023.24945 [accessed 13 August 2026]
4. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary. Weight loss outcomes depend on multiple factors including adherence to treatment, dietary modifications, and physical activity levels.